Lukas Kenner

19.1k total citations · 3 hit papers
225 papers, 10.4k citations indexed

About

Lukas Kenner is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Lukas Kenner has authored 225 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Molecular Biology, 77 papers in Oncology and 43 papers in Immunology. Recurrent topics in Lukas Kenner's work include Cytokine Signaling Pathways and Interactions (28 papers), Lymphoma Diagnosis and Treatment (22 papers) and Prostate Cancer Treatment and Research (17 papers). Lukas Kenner is often cited by papers focused on Cytokine Signaling Pathways and Interactions (28 papers), Lymphoma Diagnosis and Treatment (22 papers) and Prostate Cancer Treatment and Research (17 papers). Lukas Kenner collaborates with scholars based in Austria, Germany and United States. Lukas Kenner's co-authors include Erwin F. Wagner, Robert Eferl, Rainer Zenz, Michaela Schlederer, Harald Scheuch, Richard Moriggl, Martina Rath, Erwin Tschachler, Suzanne D. Turner and Olaf Merkel and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Lukas Kenner

212 papers receiving 10.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

p62 Is a Common Component of Cytoplasmic Inclusions in Protein Aggregation Diseases

2002 516 citations Lukas Kenner et al. profile →
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy

2015 429 citations Lukas Kenner et al. profile →
Micro- and Nanoplastics Breach the Blood–Brain Barrier (BBB): Biomolecular Corona’s Role Revealed

2023 205 citations Verena Kopatz, Verena Pichler et al. profile →

Peers

Countries citing papers authored by Lukas Kenner

Since Specialization

Citations

This map shows the geographic impact of Lukas Kenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Kenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Kenner more than expected).

Fields of papers citing papers by Lukas Kenner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukas Kenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Kenner. The network helps show where Lukas Kenner may publish in the future.

Co-authorship network of co-authors of Lukas Kenner

This figure shows the co-authorship network connecting the top 25 collaborators of Lukas Kenner. A scholar is included among the top collaborators of Lukas Kenner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukas Kenner. Lukas Kenner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Monotherapy With Immune Checkpoint Inhibitors in Patients With Recurrent and/or Metastatic Sinonasal Squamous Cell Carcinoma 2025 ·Cancer Medicine ·(unknown), Thorsten Fuereder, (unknown), Agmal Scherzad, Stephan Hackenberg, (unknown), (unknown), Gregor Heiduschka, Archana Jaiswal, Rajiv Bhalla, Lukas Kenner, Faris F. Brkic	0
2	Production of detergent-free PET and biodegradable PBAT micro- and nanoplastics 2025 ·Journal of Hazardous Materials ·(unknown), (unknown), (unknown), (unknown), Verena Kopatz, Andreas Teuschl, Lukas Kenner, Verena Pichler	1
3	Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga]Ga-PSMA-11 PET/MRI 2024 ·Insights into Imaging ·Clemens P. Spielvogel, Jing Ning, (unknown), (unknown), (unknown), (unknown), (unknown), László Papp, Bernhard Grubmüller, Shahrokh F. Shariat, Pascal Baltzer, Paola Clauser, Markus Hartenbach, Lukas Kenner, Marcus Hacker, Alexander Haug, Sazan Rasul	3
4	Targeting Androgen, Thyroid Hormone, and Vitamin A and D Receptors to Treat Prostate Cancer 2024 ·International Journal of Molecular Sciences ·Brigitte Hantusch, Lukas Kenner, (unknown), Maarten Hoogenkamp, G. E. Brown	3
5	High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients 2023 ·Journal of Cancer Research and Clinical Oncology ·(unknown), (unknown), Bernhard J. Jank, Faris F. Brkic, (unknown), Lukas Kenner, Gregor Heiduschka, (unknown)	1
6	Distinct Subtypes of Chemotherapy-Resistant Systemic ALK-Positive Anaplastic Large Cell Lymphoma Demonstrate Long-Term Complete Remissions to Imatinib 2023 ·Blood ·Alexander Pichler, Christoph Kornauth, (unknown), Lukas Kazianka, Arne Zibat, Luca Mologni, (unknown), Tea Pemovska, Gerwin Heller, Richard Greil, Lukas Kenner, Ulrich Jaeger, Philipp B. Staber	1
7	Preclinical and Clinical Observations Implying Combination Therapy to Enhance the Efficacy of the Her-2/neu B-Cell Peptide-Based Vaccine HER-Vaxx and to Prevent Immune Evasion 2023 ·International Journal of Molecular Sciences ·Joshua Tobias, Sandra Högler, (unknown), (unknown), Yee Chao, Lukas Kenner, Erika Garner‐Spitzer, (unknown), Nicholas J. Ede, Christoph Zielinski, Michael Kundi, Ursula Wiedermann	1
8	β-CATENIN is a positive prognostic marker for HPV-positive head and neck squamous cell carcinoma 2023 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Faris F. Brkic, (unknown), (unknown), Elisabeth Gurnhofer, Gregor Heiduschka, (unknown), Lukas Kenner	0
9	Spatial Proteomics for the Molecular Characterization of Breast Cancer 2023 ·Proteomes ·(unknown), Brigitte Hantusch, Lukas Kenner, Klaus Kratochwill	6
10	A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity 2021 ·Nature Communications ·(unknown), Elodie Belnoue, Matteo A. C. Rossi, Tamara Hofer, (unknown), Tobias Nolden, (unknown), (unknown), Janine Kimpel, (unknown), (unknown), Lukas Kenner, Dorotheé von Laer, Knut Elbers, Madiha Derouazi, Guido Wollmann	41
11	Proteomic Analysis Identifies NDUFS1 and ATP5O as Novel Markers for Survival Outcome in Prostate Cancer 2021 ·Cancers ·(unknown), Matteo Pecoraro, Heidi A. Neubauer, Karolína Trachtová, (unknown), (unknown), Jan Pěnčík, Gerda Egger, Christoph Krall, Richard Moriggl, Matthias Mann, Brigitte Hantusch, Lukas Kenner	4
12	Exocyst structural changes associated with activation of tethering downstream of Rho/Cdc42 GTPases 2020 ·The Journal of Cell Biology ·Guendalina Rossi, (unknown), Lukas Kenner, (unknown), (unknown), Adam Frost, Mary Munson, Patrick Brennwald	28
13	Expression of inhibitors of apoptosis proteins in salivary gland adenoid cystic carcinoma: XIAP is an independent marker of impaired cause‐specific survival 2020 ·Clinical Otolaryngology ·(unknown), Lorenz Kadletz, Bernhard J. Jank, Felicitas Oberndorfer, Faris F. Brkic, Elisabeth Gurnhofer, (unknown), Rudolf Seemann, Lukas Kenner, Gregor Heiduschka	4
14	8-Methoxypsoralen Plus Ultraviolet A Reduces the Psoriatic Response to Imiquimod in a Murine Model 2018 ·Acta Dermato Venereologica ·(unknown), Karin Wagner, Simone Tangermann, Michaela Schlederer, (unknown), Lukas Kenner, Bernhard Brüne, Peter Wolf	8
15	The RNA-binding protein tristetraprolin schedules apoptosis of pathogen-engaged neutrophils during bacterial infection 2017 ·Journal of Clinical Investigation ·Florian Ebner, Vitaly Sedlyarov, Saren Tasciyan, (unknown), Franz Kratochvill, Nina Gratz, Lukas Kenner, Andreas Villunger, Michael Sixt, Pavel Kovarik	27
16	Effect of postoperative radiotherapy in pT1pN1cM0 and pT2p/cN0cM0 oropharyngeal squamous cell carcinoma 2017 ·The Laryngoscope ·Lorenz Kadletz, Gregor Heiduschka, Axel Wolf, (unknown), (unknown), (unknown), Hermann Rogatsch, Michael Formanek, (unknown), Lukas Kenner, Hans Edmund Eckel, Markus Brunner	1
17	Conformational variation of proteins at room temperature is not dominated by radiation damage 2016 ·Journal of Synchrotron Radiation ·Silvia Russi, Ana González, Lukas Kenner, D.A. Keedy, James S. Fraser, Henry van den Bedem	47
18	Longitudinal study of murine microbiota activity and interactions with the host during acute inflammation and recovery 2014 ·The ISME Journal ·Clarissa Schwab, David Berry, Isabella Rauch, (unknown), (unknown), Eva Hainzl, Susanne Heider, Thomas Decker, Lukas Kenner, Mathias Müller, Birgit Strobl, Michael Wagner, Christa Schleper, Alexander Loy, Tim Urich	156
19	Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling 2009 ·Proceedings of the National Academy of Sciences ·(unknown), Paul Vesely, Brigitte Hantusch, Michaela Schlederer, Rainer Zenz, (unknown), G Steiner, Arabella Meixner, Peter Petzelbauer, Peter Wolf, Afschin Soleiman, Gerda Egger, Richard Moriggl, Tadamitsu Kishimoto, Erwin F. Wagner, Lukas Kenner	57
20	Down-regulation of Suppressor of Cytokine Signaling-3 Causes Prostate Cancer Cell Death through Activation of the Extrinsic and Intrinsic Apoptosis Pathways 2009 ·Cancer Research ·Martin Puhr, Frédéric R. Santer, Hannes Neuwirt, Martin Susani, Jeffrey A. Nemeth, Alfred Hobisch, Lukas Kenner, Zoran Čulig	77

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact